Pharvaris PHVS
NASDAQ PHVS
$31.01 -0.71 (-2.24%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pharvaris (PHVS) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Pharvaris (PHVS) posted Depreciation & Amortization (CF) of $208,410 for Q2 2026, up 78.7% from $116,628 a year earlier and up 70.0% from the prior quarter.

Analysis

Pharvaris (PHVS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Pharvaris was $576,017; for FY2025, it was $472,660, up 62.0% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for four consecutive years, though with a five-year compound annual growth rate of -85.9% (FY2020 to FY2025).
  • In prior years, Pharvaris' Depreciation & Amortization (CF) was $291,757 in FY2024 (+4.7%), $278,597 in FY2023 (+72.8%), $161,193 in FY2022 (+76.1%) and $91,559 in FY2021 (-100.0%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q2 2024.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last three quarters, with growth averaging 17.6% over the last six quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2022, with growth of 161.3%; the weakest was Q2 2025, with a decline of 100.0%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $122,608 (Q1 2026), $122,071 (Q4 2025) and $122,928 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Pharvaris 2.07 Bn -289,124.33 Bn 85,072.10 208,410.32
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 208,410.32
Mar 31, 2026 122,607.51
Dec 31, 2025 122,070.92
Sep 30, 2025 122,928.48
Jun 30, 2025 116,628.07
Mar 31, 2025 110,764.48
Dec 31, 2024 97,197.30
Sep 30, 2024 -148.29 Bn
Jun 30, 2024 145.41 Bn
Mar 31, 2024 72,085.54
Dec 31, 2023 71,038.93
Sep 30, 2023 -134.54 Bn
Jun 30, 2023 67,212.77
Mar 31, 2023 66,406.59
Dec 31, 2022 47,108.90
Sep 30, 2022 -68.76 Bn
Jun 30, 2022 37,715.12
Mar 31, 2022 36,868.79
Dec 31, 2021 38,170.88
Sep 30, 2021 34,146.26
API Access

Pharvaris Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PHVS&period=max&api_key=YOUR_API_KEY